AbCellera Biologics Inc.
ABCL | NASDAQ
$12.71
+$0.05 (+0.39%)
Sep 22, 2026, 12:11 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 66.17M | 79.21M | 75.13M | 35.32M | 32.88M | 23.12M | 28.83M | 32.96M | 33.06M | 35.79M | 38.03M | 50.39M | 145.18M | 181.04M | 485.43M | 603.21M | 507.34M | 489.06M | 375.22M | 443.8M | 447.65M | 431.24M |
Cost of Revenue | 16.58M | 16.58M | 7.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.55M | 16.59M | 21.8M | 66.44M | 86.78M | 71.74M | 70.14M | 45.51M | 23.62M | 23.62M | 20.01M |
Gross Profit | 49.6M | 62.63M | 67.21M | 35.32M | 32.88M | 23.12M | 28.83M | 32.96M | 33.06M | 35.79M | 38.03M | 48.84M | 128.59M | 159.24M | 418.99M | 516.44M | 435.6M | 418.92M | 329.71M | 212.27M | 216.13M | 203.32M |
Operating Income | -225.16M | -211.96M | -217.11M | -261.28M | -278.66M | -322.53M | -314.77M | -308.06M | -269.29M | -227.23M | -237.21M | -208.93M | -116.31M | -73.31M | 216.51M | 335.84M | 270.01M | 271.37M | 204.5M | 283.72M | 310.05M | 316.23M |
Interest Income | 16.33M | 23.92M | 28.33M | 31.08M | 33.91M | 36.12M | 38.47M | 40.77M | 41.91M | 42.89M | 42.25M | 31.28M | 26.09M | 16.73M | 7.64M | 7.64M | 2.08M | 665K | n/a | 98.26K | 98.26K | 98.26K |
Pretax Income | -196.77M | -174.15M | -177.6M | -204.93M | -198.79M | -210.63M | -200.4M | -202.17M | -178.81M | -168.63M | -174.03M | -156.84M | -70.98M | -39.86M | 239.1M | 355.22M | 283.66M | 288.47M | 219.15M | 290.36M | 312.64M | 321.41M |
Net Income | -164.66M | -143.96M | -146.41M | -171.68M | -165.67M | -167.87M | -162.86M | -175.8M | -153.3M | -146.9M | -146.4M | -129.14M | -73.91M | -50.16M | 158.52M | 248.36M | 200.36M | 204.82M | 153.47M | 210.52M | 229.2M | 238.23M |
Selling & General & Admin | 64.75M | 72.88M | 81.43M | 85.18M | 82.5M | 83.84M | 85.49M | 85.4M | 80.96M | 76.99M | 75.18M | 71.81M | 70.85M | 69.02M | 66.76M | 65.77M | 61.38M | 56.34M | 48.7M | 42.01M | 33.12M | 22.67M |
Research & Development | 197.77M | 191M | 186.83M | 182.81M | 168.75M | 170.47M | 167.26M | 169.81M | 166.75M | 162.3M | 175.66M | 155.28M | 143.95M | 134.16M | 107.88M | 96.84M | 87.71M | 76.07M | 62.06M | 53.48M | 43.53M | 37.63M |
Other Expenses | 12.24M | 10.72M | 16.05M | 28.61M | 60.29M | 91.34M | 90.85M | 85.82M | 54.64M | 23.73M | 24.4M | 30.68M | 30.09M | 29.37M | 27.84M | 17.98M | 16.5M | 15.14M | 14.45M | 40.96M | 37.34M | 34.71M |
Operating Expenses | 274.75M | 274.6M | 284.31M | 296.6M | 311.54M | 345.65M | 343.6M | 341.03M | 302.35M | 263.01M | 275.23M | 257.77M | 244.89M | 232.55M | 202.48M | 180.59M | 165.59M | 147.55M | 125.21M | 136.46M | 113.99M | 95M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.61M | 1.61M | 1.61M |
Selling & Marketing Expenses | 2.91M | 5.92M | 8.76M | 11.9M | 12.13M | 12.26M | 12.78M | 12.74M | 13.07M | 13.77M | 14.18M | 13.77M | 13.39M | 12.67M | 11.27M | 10.41M | 8.53M | 6.71M | 6.92M | 7.32M | 6.73M | 5.98M |
Cost & Expenses | 291.33M | 291.17M | 292.23M | 296.6M | 311.54M | 345.65M | 343.6M | 341.03M | 302.35M | 263.01M | 275.23M | 259.32M | 261.48M | 254.35M | 268.92M | 267.37M | 237.33M | 217.69M | 170.73M | 160.08M | 137.61M | 115.01M |
Income Tax Expense | -32.11M | -30.19M | -31.18M | -33.25M | -33.12M | -42.76M | -37.54M | -26.37M | -25.51M | -21.73M | -27.63M | -27.7M | 2.93M | 10.31M | 80.58M | 106.86M | 83.31M | 83.66M | 65.69M | 40.92M | 44.52M | 44.27M |
Shares Outstanding (Basic) | 305.56M | 303.07M | 298.71M | 298.88M | 298.51M | 297.69M | 294.59M | 294.85M | 294.22M | 292.72M | 290.95M | 289.5M | 288.91M | 287.77M | 286.41M | 285.32M | 284.69M | 283.9M | 279.83M | 278.93M | 272.2M | 269.7M |
Shares Outstanding (Diluted) | 305.56M | 303.07M | 298.71M | 298.88M | 298.51M | 297.69M | 294.59M | 294.85M | 294.22M | 292.72M | 290.95M | 289.5M | 288.91M | 287.77M | 301.3M | 315.82M | 284.69M | 311.48M | 314.89M | 278.93M | 272.2M | 320.28M |
EPS (Basic) | -0.54 | -0.48 | -0.49 | -0.58 | -0.56 | -0.57 | -0.56 | -0.60 | -0.53 | -0.51 | -0.51 | -0.45 | -0.26 | -0.17 | 0.56 | 0.87 | 0.70 | 0.71 | 0.55 | 0.77 | 0.84 | 0.88 |
EPS (Diluted) | -0.54 | -0.48 | -0.49 | -0.58 | -0.56 | -0.57 | -0.56 | -0.60 | -0.53 | -0.51 | -0.51 | -0.45 | -0.27 | -0.18 | 0.50 | 0.79 | 0.63 | 0.64 | 0.47 | 0.65 | 0.72 | 0.76 |
EBITDA | -160.3M | -157.61M | -168.63M | -212.36M | -197.92M | -211.2M | -204.15M | -202.41M | -195.18M | -182.63M | -192.16M | -143.25M | -51.99M | -13.25M | 276.25M | 375.11M | 308.99M | 311.64M | 241.71M | 308.36M | 328.38M | 334.63M |
EBIT | -201.55M | -188.48M | -197.45M | -247.16M | -263.78M | -308.03M | -301.15M | -294.61M | -256.5M | -213.17M | -223.05M | -180.4M | -88.45M | -48.5M | 243.14M | 352.51M | 288.91M | 293.38M | 224.46M | 292.65M | 315.93M | 325.32M |
Depreciation & Amortization | 41.25M | 30.87M | 28.82M | 34.8M | 65.86M | 96.84M | 97M | 92.21M | 61.32M | 30.54M | 30.89M | 37.15M | 36.46M | 35.25M | 33.1M | 22.61M | 20.08M | 18.26M | 17.25M | 14.99M | 11.73M | 8.59M |
Add to Watchlist
Select watchlists to add or remove ABCL